TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis

Cell

Volumn 126, Issue 1, 2006, Pages 107-120

  Bensaad, Karim ^a   Tsuruta, Atsushi ^a   Selak, Mary A ^a   Vidal, M Nieves Calvo ^b   Nakano, Katsunori ^a   Bartrons, Ramon ^b   Gottlieb, Eyal ^a   Vousden, Karen H ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE 2,6 BISPHOSPHATE; PROTEIN; PROTEIN P53; PROTEIN TIGAR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; GENOMICS; GLYCOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRESS;

EID: 33745918951     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.05.036     Document Type: Article

References (43)

1. Bazan J.F., Fletterick R.J., and Pilkis S.J. Evolution of a bifunctional enzyme: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Proc. Natl. Acad. Sci. USA 86 (1989) 9642-9646
2. Boada J., Roig T., Perez X., Gamez A., Bartrons R., Cascante M., and Bermudez J. Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress. FEBS Lett. 480 (2000) 261-264
3. Budanov A.V., Sablina A.A., Feinstein E., Koonin E.V., and Chumakov P.M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304 (2004) 596-600
4. Chen K., Albano A., Ho A., and Keaney J.F.J. Activation of p53 by oxidative stress involved platelet-derived growth factor-beta receptor mediated ataxia telangiectasia mutated (ATM) kinase activation. J. Biol. Chem. 278 (2003) 39527-39533
5. Chesney J., Mitchell R., Benigni F., Bacher M., Spiegel L., Al-Abed Y., Han J.H., Metz C., and Bucala R. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc. Natl. Acad. Sci. USA 96 (1999) 3047-3052
6. Fico A., Paglialunga F., Cigliano L., Abrescia P., Verde P., Martini G., Iaccarino I., and Filosa S. Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Differ. 11 (2004) 823-831
7. Hollstein M., Hergenhahn M., Yang Q., Bartsch H., Wang Z.Q., and Hainaut P. New approaches to understanding p53 gene tumor mutation spectra. Mutat. Res. 431 (1999) 199-209
8. Hsiao C.-H., Li W., Lou T.-F., Baliga B.S., and Pace B.S. Fetal hemoglobin induction by histone deacetylase inhibitors involved generation of reactive oxygen species. Exp. Hematol. 34 (2006) 264-273
9. Huang H.-L., Fang L.-W., Lu S.-P., Chou C.-K., Luh T.-Y., and Lai M.-Z. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 22 (2003) 8168-8177
10. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K.H., Han J., Chittenden T., Ihle J.N., et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4 (2003) 321-328
11. Jen K.-Y., and Cheung V.G. Identification of novel p53 target genes in ionizing radiation response. Cancer Res. 65 (2005) 7666-7673
12. Johnson T.M., Yu Z.-X., Ferrans V.J., Lowenstein R.A., and Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 93 (1996) 11848-11852
13. Kletzien R.F., Harris P.K., and Foellmi L.A. Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J. 8 (1994) 174-181
14. Lain S., and Lane D. Improving cancer therapy by non-genotoxic activation of p53. Eur. J. Cancer 39 (2003) 1053-1060
15. Le Goffe C., Vallette G., Charrier L., Candelon T., Bou-Hanna C., Bouhours J.F., and Laboisse C.L. Metabolic control of resistance of human epithelial cells to H2O2 and NO stresses. Biochem. J. 364 (2002) 349-359
16. Li P.-F., Dietz R., and von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18 (1999) 6027-6036
17. Liang Y., Buettger C., Berner D.K., and Matschinsky F.M. Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta-cell line (beta HC9). Diabetologia 40 (1997) 1018-1027
18. Lin K., Li L., Correia J.J., and Pilkis S.J. Glu327 is part of a catalytic triad in rat liver fructose-2,6-bisphosphatase. J. Biol. Chem. 267 (1992) 6556-6562
19. Ludwig R.L., Bates S., and Vousden K.H. Differential transcriptional activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol. 16 (1996) 4952-4960
20. Macip S., Igarashi M., Berggren P., Yu J., Lee S.W., and Aaronson S.A. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23 (2003) 8576-8585
21. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192 (2002) 1-15
22. Nakano K., Balint E., Ashcroft M., and Vousden K.H. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 19 (2000) 4283-4289
23. Nissler K., Petermann H., Wenz I., and Brox D. Fructose 2,6-bisphosphate metabolism in Ehrlich ascites tumour cells. J. Cancer Res. Clin. Oncol. 121 (1995) 739-745
24. Okar D.A., Manzano A., Navarro-Sabate A., Riera L., Bartrons R., and Lange A.J. PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem. Sci. 26 (2001) 30-35
25. Ozer N., Aksoy Y., and Ogus I.H. Kinetic properties of human placental glucose-6-phosphate dehydrogenase. Int. J. Biochem. Cell Biol. 33 (2001) 221-226
26. Perez J.X., Roig T., Manzano A., Dalmau M., Boada J., Ventura F., Rosa J.L., Bermudez J., and Bartrons R. Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression. Am. J. Physiol. Cell Physiol. 279 (2000) C1359-C1365
27. Polyak K., Waldman T., He T.-C., Kinzler K.W., and Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10 (1996) 1945-1952
28. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
29. Rowan S., Ludwig R.L., Haupt Y., Bates S., Lu X., Oren M., and Vousden K.H. Specific loss of apoptotic but not cell cycle arrest function in a human tumour derived p53 mutant. EMBO J. 15 (1996) 827-838
30. Sablina A.A., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., and Chumakov P.M. The antioxidant function of the p53 tumor suppressor gene. Nat. Med. 11 (2005) 1306-1313
31. Sengupta S., and Harris C.C. p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 6 (2005) 44-55
32. Tian W.N., Braunstein L.D., Apse K., Pang J., Rose M., Tian X., and Stanton R.C. Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am. J. Physiol. 276 (1999) C1121-C1131
33. Tsang W.P., Chau S.P., Kong S.K., Fung K.P., and Kwok T.T. Reactive oxygen species mediate doxorubicin induced p53-indepenent apoptosis. Life Sci. 73 (2003) 2047-2058
34. Vander Heiden M.G., Plas D.R., Rathmell J.C., Fox C.J., Harris M.H., and Thompson C.B. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21 (2001) 5899-5912
35. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., King N., Kammlott U., Lukacs C., Klein C., et al. In vivo activation of the p53 pathway by small-molecular antagonists of MDM2. Science 303 (2004) 844-848
36. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., and Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302 (2003) 1036-1038
37. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
38. Vousden K.H. p53: death star. Cell 101 (2000) 691-694
39. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
40. Waldman T., Kinzler K.W., and Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55 (1995) 5187-5190
41. Warburg O. On the origin of cancer cells. Science 123 (1956) 309-314
42. Yoon K.A., Nakamura Y., and Arakawa H. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J. Hum. Genet. 49 (2004) 134-140
43. Zhang Y.M., Liu J.K., and Wong T.Y. The DNA excision repair system of the highly radioresistant bacterium Deinococcus radiodurans is facilitated by the pentose phosphate pathway. Mol. Microbiol. 48 (2003) 1317-1323